New cancer clinical trial: SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical Cancer

Published on: January 25, 2019 at 12:00PM
Conditions:   Recurrent Cervical Carcinoma;   Metastatic Cervical Cancer
Interventions:   Drug: SHR-1210;   Drug: Apatinib
Sponsor:   Sun Yat-sen University
Recruiting
http://bit.ly/2SdcyHk